Zabofloxacin

[{"orgOrder":0,"company":"IASO Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Zabofloxacin","moa":"Bacterial DNA gyrase | Topoisomerase IV","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"IASO Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"IASO Pharma \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"IASO Pharma \/ Undisclosed"},{"orgOrder":0,"company":"DongWha Pharm","sponsor":"Chonbuk National University Hospital | Chosun University Hospital | Bundang CHA Hospital | Chungbuk National University | Kangdong Sacred Heart Hospital | Hanyang University | Asan Medical Center | Gachon University Gil Medical Center | Catholic Universit","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"SOUTH KOREA","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Zabofloxacin","moa":"Bacterial DNA gyrase | Topoisomerase IV","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase III","graph3":"DongWha Pharm","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"DongWha Pharm \/ Chonbuk National University Hospital | Chosun University Hospital | Bundang CHA Hospital | Chungbuk National University | Kangdong Sacred Heart Hospital | Hanyang University | Asan Medical Center | Gachon University Gil Medical Center | Catholic Universit","highestDevelopmentStatusID":"10","companyTruncated":"DongWha Pharm \/ Chonbuk National University Hospital | Chosun University Hospital | Bundang CHA Hospital | Chungbuk National University | Kangdong Sacred Heart Hospital | Hanyang University | Asan Medical Center | Gachon University Gil Medical Center | Catholic Universit"},{"orgOrder":0,"company":"DongWha Pharm","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SOUTH KOREA","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Zabofloxacin","moa":"Bacterial DNA gyrase | Topoisomerase IV","graph1":"Undisclosed","graph2":"Phase I","graph3":"DongWha Pharm","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"DongWha Pharm \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"DongWha Pharm \/ Undisclosed"}]